Compositions and methods for cystic fibrosis therapy

Details Compositions and methods for cystic fibrosis therapy Compositions and methods for cystic fibrosis therapy

1997-10-16

1999-10-26

Weddington, Kevin E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514513, 514851, A61K 3135, A61K 3121

Patent

active

059729953

ABSTRACT:
Compositions and methods for therapy of cystic fibrosis and other conditions are provided. The compositions comprise one or more flavones and/or isoflavones capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis and/or another condition responsive to stimulation of chloride transport.

REFERENCES:
patent: 5639661 (1997-06-01), Welsh et al.
patent: 5650433 (1997-07-01), Watanabe et al.
patent: 5733926 (1998-03-01), Gorbach
patent: 5756538 (1998-05-01), Cassels et al.
Brown et al., "Chemical chaperones correct the mutant phenotype of the .DELTA.F508 cystic fibrosis transmembrane conductance regulatory protein," Cell Stress & Chaperones 1(2): 117-125, 1996.
Hwang et al., "Genistein potentiates wild-type and .DELTA.F508-CFTR channel activity," American Journal of Physiology273(3, part 1): C988-C-998, 1997.
Scott and Cooperstein, "Ascorbic acid stimulates chloride transport in the amphilbian cornea," Investigative Ophtalmology 14(10): 763-766, 1975.
Smith, "Treatment of cystic fibrosis based on understanding CFTR," J. Inher. Metab. Dis 18:508-516, 1995.
Rubenstein et al., "In Vitro Pharmacologic Restoration of CFTR-mediated Chloride Transport with Sodium 4-Phenylbutyrate in Cystic Fibrosis Epithelial Cells," J. Clin. Invest. 100(10): 2457-2465, 1997.
Sheppard et al., "Mutations in CFTR associated with mild-disease-form CI channels with altered pore properties," Nature 362: 160-164, 1993.
Anderson, et al., "Generation of cAMP-Activated Chloride Currents by Expression of CFTR," Science 251:679-682, 1991.
Knowles et al., "In Vivo Nasal Potential Difference: Techniques and Protocols for Assessing Efficacy of Gene Transfer in Cystic Fibrosis," Human Gene Therapy 6: 445-455, 1995.
Riordan et al., "Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA," Science 245: 1066-1073, 1989.
Illek et al., "cAMP-independent activation of CFTR C1 channels by the tyrosine kinase inhibitor genistein," Cell Physiol. 37: C886-C893, 1995.

Affiliated with

Also associated with

Rating

Compositions and methods for cystic fibrosis therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for cystic fibrosis therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for cystic fibrosis therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-765223